Press Releases

All Releases
Dec 21, 2023
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Dec. 21, 2023-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today
Aug 03, 2023
AngioDynamics Completes Enrollment for PRESERVE Clinical Study
Pivotal Study of NanoKnife System for Ablation of Prostate Tissue in an Intermediate-Risk Patient Population LATHAM, N.Y. --(BUSINESS WIRE)--Aug. 3, 2023-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the
Apr 11, 2023
AngioDynamics to Present at the Needham Virtual Healthcare Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Apr. 11, 2023-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today
Feb 28, 2023
AngioDynamics to Participate in Three Investor Conferences in March
LATHAM, N.Y. --(BUSINESS WIRE)--Feb. 28, 2023-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today
Displaying 1 - 20 of 726